• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7
1

CATEGORIES

  • 64
  • 19
  • 16
  • 9
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

25
29
45
125

PUBLISHED

3
6
29
125

PRODUCT TYPE

83
40
1
1

Search "Neuropathy Therapy Area Pipeline Report" returned 125 results.

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

January 2015
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014’, provides an overview of the Peripheral...

August 2014
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014’, provides an overview...

March 2014
FROM

Diabetic Neuropathy - Pipeline Review, H1 2015

Diabetic Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report...

June 2015
FROM

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2014

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Diabetic Peripheral Neuropathy’s therapeutic...

October 2014
FROM

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Peripheral Neuropathy’s therapeutic...

January 2015
FROM

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2014

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2014’, provides an overview of the Diabetic Peripheral...

May 2014
FROM

Optic Neuropathy - Pipeline Review, H1 2015

Optic Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Optic Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Optic Neuropathy’s therapeutic pipeline. This report provides...

January 2015
FROM

Optic Neuropathy - Pipeline Review, H2 2014

Optic Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Optic Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Optic Neuropathy’s therapeutic pipeline. This report provides...

December 2014
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy...

December 2014
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy...

February 2015
FROM

Diabetic Neuropathy - Pipeline Review, H1 2014

Diabetic Neuropathy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H1 2014’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This...

March 2014
FROM

Diabetic Neuropathy - Pipeline Review, H2 2014

Diabetic Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Diabetic Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report...

August 2014
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

August 2015
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014’, provides an overview...

June 2014
FROM

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2014

Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline...

May 2014
FROM

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015

Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015 Summary This, ‘Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015’,...

February 2015
FROM

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H2 2014

Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H2 2014 Summary This, ‘Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H2 2014’,...

November 2014
FROM

Peripheral Neuropathy and Neuropathic Pain 2008

This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally PN and NP are causally linked to a number of diseases, however diabetes,...

June 2009
FROM
Pain Therapeutics - Drugs, Markets and Companies Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

August 2015
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group